Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Utilities, Technology and Telecoms sectors led shares higher while losses in the Basic Materials, Consumer Goods and Consumer Services sectors led shares lower.
At the close in NYSE, the Dow Jones Industrial Average rose 0.12%, while the S&P 500 index gained 0.07%, and the NASDAQ Composite index lost 0.11%.
The best performers of the session on the Dow Jones Industrial Average were Merck & Company Inc (NYSE:MRK), which rose 3.95% or 4.22 points to trade at 111.10 at the close. Meanwhile, Apple Inc (NASDAQ:AAPL) added 1.85% or 2.80 points to end at 153.83 and Coca-Cola Co (NYSE:KO) was up 1.55% or 0.92 points to 60.36 in late trade.
The worst performers of the session were Dow Inc (NYSE:DOW), which fell 2.07% or 1.21 points to trade at 57.11 at the close. Walgreens Boots Alliance Inc (NASDAQ:WBA) declined 1.77% or 0.64 points to end at 35.45 and Intel Corporation (NASDAQ:INTC) was down 1.55% or 0.41 points to 25.99.
The top performers on the S&P 500 were Lumen Technologies Inc (NYSE:LUMN) which rose 4.10% to 3.30, Merck & Company Inc (NYSE:MRK) which was up 3.95% to settle at 111.10 and Enphase Energy Inc (NASDAQ:ENPH) which gained 3.77% to close at 225.35.
The worst performers were DexCom Inc (NASDAQ:DXCM) which was down 7.87% to 113.25 in late trade, Newell Brands Inc (NASDAQ:NWL) which lost 7.23% to settle at 13.48 and VF Corporation (NYSE:VFC) which was down 5.37% to 24.85 at the close.
The top performers on the NASDAQ Composite were Appreciate Holdings Inc (NASDAQ:SFR) which rose 152.89% to 3.06, Unicycive Therapeutics Inc (NASDAQ:UNCY) which was up 153.06% to settle at 1.24 and Bellerophon Therapeutics Inc (NASDAQ:BLPH) which gained 94.11% to close at 3.51.
The worst performers were Aclaris Therapeutics Inc (NASDAQ:ACRS) which was down 44.68% to 7.07 in late trade, Rubius Therapeutics Inc (NASDAQ:RUBY) which lost 33.55% to settle at 0.08 and Embark Technology Inc (NASDAQ:EMBK) which was down 32.81% to 2.56 at the close.
Falling stocks outnumbered advancing ones on the New York Stock Exchange by 1972 to 1052 and 97 ended unchanged; on the Nasdaq Stock Exchange, 2429 fell and 1234 advanced, while 125 ended unchanged.
Shares in Aclaris Therapeutics Inc (NASDAQ:ACRS) fell to 52-week lows; down 44.68% or 5.71 to 7.07. Shares in Rubius Therapeutics Inc (NASDAQ:RUBY) fell to 3-years lows; falling 33.55% or 0.04 to 0.08. Shares in Bellerophon Therapeutics Inc (NASDAQ:BLPH) rose to 52-week highs; gaining 94.11% or 1.70 to 3.51.
The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was up 0.65% to 18.61.
Gold Futures for April delivery was down 0.12% or 2.20 to $1,852.40 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in April rose 1.10% or 0.88 to hit $80.56 a barrel, while the May Brent oil contract rose 0.55% or 0.47 to trade at $86.30 a barrel.
EUR/USD was unchanged 0.43% to 1.07, while USD/JPY rose 0.06% to 135.93.
The US Dollar Index Futures was down 0.20% at 104.28.